About Me

• I am a biostatistician in the Translational Biomarker Statistics group of Pfizer. My work mainly focuses on identifying biomarkers that are associated with clinical endpoints, such as efficacy, adverse events and PK/PD parameters, across phase I-III clinical trials. Previously I also worked for Merck Research Laboratories, Merck & Co., Inc. in the area of pharmacogenetics.
• I received my Bachelor’s degree in Mathematics and Finance from Wuhan University, Master’s degree in Financial Mathematics from Johns Hopkins University and PhD in Statistics from Worcester Polytechnic Institute. My PhD advisor is Prof. Zheyang Wu.